small
anim
model
emerg
viral
pathogenesi
fundament
tool
understand
molecular
genet
mechan
drive
sever
diseas
outcom
infect
model
essenti
systemat
dissect
viral
host
determin
diseas
present
key
critic
evalu
vaccin
antivir
vivo
maxim
util
impact
biolog
relev
pathogenesi
studi
therapeut
evalu
measur
multipl
complementari
translat
metric
time
crucial
emerg
viral
pathogen
like
ebola
viru
yellow
fever
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
eastern
respiratori
syndrom
coronaviru
merscov
major
threat
global
public
health
viral
emerg
typic
result
zoonot
viru
spill
anim
reservoir
human
popul
without
preexist
immun
vaccin
therapeut
newli
emerg
viral
pathogen
sustain
human
human
transmiss
coupl
eas
frequenc
human
travel
could
fuel
explos
catastroph
global
pandem
diseas
merscov
discov
emerg
bat
camel
intermedi
host
middl
east
thu
far
caus
case
death
countri
virus
similar
sar
merscov
current
circul
bat
make
emerg
sar
merslik
viru
futur
real
possibl
current
approv
vaccin
therapi
specif
human
cov
complet
blood
count
cbc
routin
rapid
hematolog
test
aid
diagnosi
blood
disord
infecti
diseas
million
cbc
order
unit
state
make
request
clinic
lab
test
moreov
cbc
perform
without
special
machineri
expens
equip
provid
key
clinic
inform
diseas
manag
patient
even
rural
resourc
limit
set
exampl
cbc
describ
thrombocytopenia
lymphopenia
patient
sarscov
merscov
increas
absolut
neutrophil
count
earli
sarscov
infect
strong
predictor
intens
care
unit
icu
admiss
death
studi
character
daili
variat
differ
peripher
blood
cell
popul
mous
model
merscov
infect
pathogenesi
day
post
infect
dpi
peripher
blood
analyz
autom
veterinari
hematolog
analyz
biosafeti
level
routin
flow
cytometri
techniqu
similar
observ
human
merscov
patient
observ
signific
modul
leukocyt
merscov
infect
mice
viru
dose
depend
measur
prior
notabl
weight
loss
importantli
neutrophil
count
predict
diseas
sever
lethal
dose
merscov
highlight
predict
valu
hematolog
model
data
highlight
predict
valu
clinic
translat
cbc
studi
emerg
viru
pathogenesi
therefor
approach
elev
futur
studi
dissect
host
factor
drive
sever
merscov
diseas
preclin
evalu
therapeut
vaccin
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
committe
ethic
anim
experi
univers
north
carolina
chapel
hill
protocol
number
previous
modifi
murin
ortholog
human
merscov
receptor
dipeptidyl
peptidas
mice
substitut
human
residu
posit
thu
render
mice
suscept
merscov
infect
result
mice
express
human
refer
herein
hous
accord
guidelin
set
depart
laboratori
anim
medicin
univers
north
carolina
chapel
hill
mice
acclim
environ
one
week
prior
infect
tenweek
femal
mice
randomli
assign
treatment
group
anaesthet
ketamin
xylazin
infect
intranas
x
plaqu
form
unit
pfu
mous
adapt
merscov
viru
collect
medium
optimem
gibco
fetal
clone
serum
product
hyclon
antibioticantimycot
gibco
nonessenti
amino
acid
gibco
merscov
previous
publish
clonal
isol
gener
passag
mice
subsequ
plaqu
purifi
clone
expand
two
time
vero
cell
obtain
work
stock
grown
viru
collect
medium
bodi
weight
measur
daili
monitor
progress
viru
associ
morbid
mortal
subset
mice
euthan
via
isofluoran
overdos
lung
harvest
day
one
two
three
four
infect
inferior
right
lobe
frozen
util
measur
lung
viral
load
via
plaqu
assay
result
describ
herein
deriv
two
independ
studi
measur
fluctuat
blood
cell
live
mice
infect
lethal
subleth
dose
merscov
infect
old
male
femal
mice
pb
pfu
mer
describ
bodi
weight
measur
daili
day
post
infect
mice
bled
via
submandibular
rout
blood
analyz
via
vetscan
mice
sacrif
inferior
right
lung
lobe
harvest
frozen
util
measur
viru
lung
titer
plaqu
assay
describ
bronchoalveolar
lavag
bal
suspens
collect
immedi
follow
euthanasia
gentli
inject
steril
pb
mous
lung
caviti
trachea
use
cathet
attach
syring
second
maximum
recover
volum
pb
gener
collect
store
eppendorf
tube
prompt
vetscan
analysi
pb
aspir
reinject
due
delic
natur
lung
tissu
follow
merscov
infect
lanc
posterior
vena
cava
peripher
blood
collect
edta
tube
sarstedt
prevent
coagul
hematolog
analysi
blood
sampl
dilut
pb
analyz
via
vetscan
abaxi
see
remain
bal
blood
sampl
save
flow
cytometr
analys
see
peripher
blood
collect
note
dilut
pbsedta
directli
analyz
vetscan
abaxi
fulli
autom
hematolog
analyz
place
within
biolog
safeti
cabinet
vetscan
discrimin
cell
type
achiev
size
follow
paramet
analyz
lymphocyt
lym
neutrophil
neu
monocyt
mon
basophil
ba
eosinophil
eo
report
absolut
cell
count
well
percentag
total
white
blood
cell
wbc
red
blood
cell
rbc
hemoglobin
hgb
hematocrit
hct
mean
corpuscular
volum
mcv
mean
corpuscular
hemoglobin
mch
mean
corpuscular
hemoglobin
concentr
mchc
red
blood
cell
distribut
width
rdwc
platelet
plt
plateletcrit
pct
mean
platelet
volum
mpv
platelet
distribut
width
pdwc
valid
vetscan
report
valu
perform
flow
cytometri
ident
bal
whole
blood
sampl
vetscan
analysi
remain
bal
whole
peripher
blood
sampl
stain
flow
cytometri
antibodi
use
evalu
cellular
composit
blood
clone
ebiosci
clone
clone
clone
clone
clone
clone
ebiosci
antibodi
purchas
biolegend
unless
otherwis
note
titrat
prior
use
sampl
also
treat
fixabl
livedead
dye
invitrogen
exclud
dead
cell
downstream
analys
follow
antibodi
stain
erythrocyt
lyse
use
rbc
lysi
buffer
biolegend
sampl
acquir
use
lsrii
cytomet
bd
bioscienc
analyz
use
flowjo
softwar
treestar
sampl
peripher
blood
sampl
run
live
singlet
event
acquir
possibl
rang
mean
total
event
bal
sampl
acquir
deplet
result
minimum
event
rang
mean
event
analysi
sampl
gate
first
remov
debri
multiplet
event
nonviabl
cell
posit
gate
set
use
fluoresc
minu
one
stain
control
addit
express
cellular
popul
defin
lymphocyt
includ
cell
b
cell
nk
cell
nk
cell
ii
monocyt
iii
neutrophil
cell
popul
assign
reflect
measur
vetscan
data
analyz
use
graphpad
prism
graphpad
prism
softwar
san
diego
california
specif
statist
test
determin
signific
note
figur
legend
util
establish
transgen
mous
model
merscov
pathogenesi
studi
murin
ortholog
human
receptor
dipeptidyl
peptidas
human
residu
mice
facilit
infect
pathogenesi
reminisc
human
infect
mice
either
pb
mock
pfu
mous
adapt
merscov
strain
harvest
blood
lung
tissu
analysi
day
infect
four
day
fig
unlik
mock
infect
mice
merscov
infect
mice
lost
signific
p
bodi
weight
time
fig
expect
yet
crude
marker
merscov
pathogenesi
similarli
observ
rapid
high
titer
merscov
replic
lung
tissu
peak
day
post
infect
titer
slightli
reduc
p
fig
determin
hematolog
paramet
modul
merscov
infect
analyz
peripher
blood
mock
merscov
infect
mice
time
point
vetscan
hematolog
analyz
tabl
vetscan
provid
fulli
autom
report
complet
blood
count
cbc
whole
blood
discrimin
quantifi
cell
number
base
cell
size
preval
white
blood
cell
popul
lymphocyt
neutrophil
monocyt
enumer
cellsl
also
report
percentag
total
white
blood
cell
wbc
importantli
machin
place
biosafeti
cabinet
process
infecti
sampl
biosafeti
level
mock
merscov
infect
anim
level
total
wbc
significantli
modul
time
consist
unvari
cell
count
frequenc
read
obtain
time
point
rang
p
fig
number
frequenc
lymphocyt
monocyt
neutrophil
invari
time
mock
infect
mice
popul
significantli
modul
merscov
infect
anim
cell
number
frequenc
highli
correl
fig
fig
neutrophil
p
monocyt
p
count
frequenc
neutrophil
p
monocyt
p
significantli
elev
merscov
infect
anim
number
frequenc
neutrophil
remain
elev
slowli
wane
cours
experi
monocyt
variat
cell
number
frequenc
prevent
determin
statist
differ
infect
mock
group
fig
infect
anim
number
lymphocyt
significantli
reduc
p
compar
mock
similarli
lymphocyt
frequenc
reduc
infect
anim
metric
ie
rbc
count
hemoglobin
hematocrit
platelet
etc
measur
vetscan
modul
merscov
infect
fig
importantli
vetscan
phenotyp
describ
combin
data
reproduc
across
two
independ
experi
fig
taken
togeth
system
immun
activ
detect
peripher
blood
follow
merscov
infect
prior
onset
sever
weight
loss
yet
signific
viru
replic
lung
sinc
vetscan
discrimin
cell
popul
base
size
sought
valid
accuraci
use
phenotyp
stain
pair
sampl
via
flow
cytometri
vetscan
design
enumer
absolut
cell
number
anticoagul
peripher
blood
prepar
blood
sampl
flow
cytometri
requir
addit
process
eg
red
blood
cell
lysi
report
rel
cell
frequenc
base
cell
surfac
marker
stain
cell
surfac
marker
uniqu
marker
ubiquit
express
white
blood
cell
similar
vetscan
measur
total
white
blood
cell
frequenc
cell
observ
mock
merscov
infect
anim
consist
invari
time
fig
singl
common
lymphocyt
surfac
marker
exist
combin
independ
frequenc
cell
b
cell
nk
cell
nk
cell
subset
gener
aggreg
lymphocyt
frequenc
captur
cell
type
quantifi
lymphocyt
vetscan
notabl
observ
decreas
frequenc
lymphocyt
thu
valid
lymphopenia
measur
vetscan
similarli
monocyt
neutrophil
frequenc
measur
flow
cytometri
blood
significantli
elev
follow
merscov
infect
compar
mock
infect
mice
mirror
observ
vetscan
fig
perform
pearson
correl
analysi
compar
frequenc
lymphocyt
neutrophil
monocyt
flow
cytometri
vetscan
unlik
mock
infect
anim
show
correl
among
cell
frequenc
cell
type
fig
lymphocyt
p
neutrophil
p
frequenc
data
merscov
infect
mice
highli
correl
flow
cytometri
vetscan
fig
lastli
overal
trend
cell
popul
frequenc
modul
measur
either
flow
cytometri
vetscan
entir
time
cours
remark
similar
fig
thu
two
independ
techniqu
gener
similar
result
demonstr
modul
peripher
leukocyt
popul
follow
merscov
infect
mice
determin
number
leukocyt
peripher
blood
earli
merscov
infect
predict
diseas
sever
infect
week
old
male
femal
mice
either
pb
mock
pfu
mer
dose
previous
shown
caus
subleth
lethal
diseas
model
sinc
analysi
perform
blood
termin
cardiac
punctur
studi
bled
live
mock
merscov
infect
mice
via
submandibular
bleed
obtain
longitudin
cbc
data
per
mous
addit
studi
describ
previou
figur
perform
dose
merscov
ie
pfu
describ
fig
similar
previous
report
data
observ
merscov
dose
depend
weight
loss
subleth
lethal
dose
merscov
group
significantli
differ
begin
fig
p
valu
rang
p
p
viru
lung
titer
also
differ
among
infect
group
p
fig
see
signific
differ
total
wbc
count
among
mock
merscov
infect
pfu
mice
fig
observ
viru
dose
depend
differ
metric
compar
mock
subleth
lethal
dose
merscov
fig
although
increas
wbc
dose
viru
compar
mock
infect
leukopenia
observ
fig
cbc
deriv
cardiac
punctur
submandibular
bleed
mice
shown
other
equival
thu
differ
wbc
trend
fig
like
bleed
rout
like
relat
differ
viru
dosag
andor
slight
differ
number
measur
cell
ie
lymphocyt
monocyt
neutrophil
etc
reveal
fig
obscur
fig
trend
wbc
metric
similar
fig
merscov
infect
caus
signific
lymphopenia
subleth
lethal
dose
viru
fig
addit
number
neutrophil
elev
lethal
dose
increas
kinet
delay
subleth
dose
fig
thu
neutrophil
elev
kinet
peripher
blood
differenti
modul
viru
dose
fig
importantli
mice
infect
lethal
dose
merscov
posit
correl
weight
loss
percentag
total
number
neutrophil
blood
fig
data
demonstr
level
peripher
blood
leukocyt
correl
merscov
diseas
dose
depend
manner
specif
neutrophil
number
peripher
blood
mice
infect
lethal
dose
merscov
predict
diseas
sever
establish
util
vetscan
perform
routin
hematolog
merscov
infect
mice
evalu
potenti
vetscan
character
leukocyt
extrahematolog
sampl
directli
relev
respiratori
infect
bronchoalveolar
lavag
bal
vetscan
instrument
requir
minimum
cell
densiti
gener
read
found
bal
sampl
gener
measur
result
use
vetscan
certain
experiment
condit
although
abl
character
bal
isol
cell
flow
cytometri
manuscript
prepar
anim
regardless
infect
statu
vetscan
intermitt
provid
reliabl
read
merscov
infect
anim
late
time
post
infect
tabl
thu
bal
sampl
mock
merscov
infect
exceed
threshold
requir
gener
reliabl
enumer
vetscan
attempt
overcom
issu
concentr
bal
sampl
still
unabl
gener
reliabl
read
mock
merscov
infect
anim
thu
without
optim
enumer
immun
cell
bal
via
vetscan
flow
cytometri
remain
ideal
applic
evalu
immun
popul
dynam
kind
sampl
anim
model
emerg
viral
diseas
essenti
provid
insight
viru
host
determin
pathogenesi
facilit
evalu
experiment
therapeut
maxim
translat
model
method
noninvas
longitudin
data
collect
multipl
metric
individu
anim
reminisc
collect
human
patient
need
moreov
model
often
reli
anim
weight
loss
rel
nonspecif
marker
chronicl
diseas
may
overlook
critic
marker
diseas
progress
sever
due
ubiqu
cbc
diagnosi
triag
emerg
viral
diseas
sought
establish
techniqu
better
understand
modul
blood
cell
mous
model
merscov
pathogenesi
thu
increas
translat
human
condit
kinet
studi
compar
data
gener
autom
veterinari
hematolog
analyz
vetscan
standard
flow
cytometri
unlik
flow
cytometri
report
rel
cell
frequenc
defin
antigen
stain
vetscan
identifi
enumer
promin
blood
cell
type
base
size
furthermor
vetscan
measur
sever
paramet
addit
cell
frequenc
within
singl
read
eg
platelet
hematocrit
hemoglobin
etc
merscov
mous
model
determin
vetscan
could
accur
measur
fluctuat
major
immun
cell
popul
ie
lymphocyt
monocyt
neutrophil
mirror
result
gener
flow
cytometri
merscov
infect
observ
lymphopenia
neutrophilia
elev
monocyt
peripher
blood
two
differ
methodolog
importantli
demonstr
diseas
sever
could
differenti
cbc
perform
daili
longitudin
studi
mice
infect
either
subleth
lethal
dose
merscov
flow
cytometri
gold
standard
use
character
immun
cell
popul
techniqu
requir
technic
expertis
expens
reagent
equip
often
signific
sampl
process
time
especi
work
biosafeti
procedur
complic
alreadi
complex
process
vetscan
offer
simpl
rapid
altern
flow
cytometri
aim
understand
gener
respons
peripher
blood
emerg
model
viral
pathogenesi
especi
studi
environ
thu
data
vetscan
could
serv
inform
experiment
design
ie
choos
timepoint
simplifi
rigor
immun
cell
phenotyp
flow
cytometri
pathogen
small
anim
model
emerg
viral
pathogenesi
fundament
tool
understand
human
infecti
diseas
model
essenti
systemat
dissect
viral
host
determin
diseas
key
critic
evalu
vaccin
antivir
maxim
util
impact
biolog
relev
pathogenesi
studi
therapeut
evalu
measur
multipl
complementari
translat
metric
crucial
recent
sever
transgen
mous
model
gener
background
facilit
studi
merscov
pathogenesi
modif
murin
ortholog
human
merscov
receptor
dipeptidyl
peptidas
although
genet
approach
vari
complet
replac
murin
human
replac
exon
mous
human
singl
amino
acid
chang
residu
human
murin
model
offer
complementari
insight
viral
host
factor
contribut
sever
lung
diseas
merscov
infect
one
studi
perform
cbc
perform
manual
blood
smear
obtain
percentag
lymphocyt
monocyt
neutrophil
dpi
nevertheless
data
li
et
al
report
mous
adapt
merscov
infect
transgen
mice
concord
report
herein
overal
reduct
lymphocyt
percentag
increas
monocyt
neutrophil
interestingli
use
blood
smear
robert
et
al
report
lymphopenia
neutrophilia
follow
infect
balbc
mice
mous
adapt
sarscov
strain
thu
vetscan
potenti
util
character
biolog
multipl
model
emerg
cov
diseas
viral
infect
often
caus
alter
peripher
blood
cell
popul
frequenc
diseas
progress
combin
tool
commonli
util
aid
diagnosi
treatment
ie
patient
histori
physic
exam
vital
sign
blood
chemistri
etc
thorough
understand
kinet
blood
cell
popul
modul
help
determin
stage
infect
clinic
sever
inform
possibl
therapeut
avenu
exampl
even
sarscov
identifi
etiolog
agent
sarscov
outbreak
clinician
hong
kong
note
elev
neutrophil
count
upon
admiss
patient
sarscov
continu
declin
lymphocyt
count
first
week
hospit
addit
advanc
age
elev
serum
lactat
dehydrogenas
elev
neutrophil
count
admiss
predictor
advers
outcom
mani
clinic
manifest
sarscov
infect
lymphopenia
elev
neutrophil
increas
serum
ldh
also
observ
merscov
patient
thu
observ
report
decreas
number
lymphocyt
increas
neutrophil
peripher
blood
merscov
infect
mice
faith
recapitul
manifest
infect
human
fact
compar
longitudin
studi
compar
subleth
lethal
dose
merscov
fig
found
neutrophil
number
peripher
blood
correl
degre
bodi
weight
loss
lethal
dose
group
thu
lethal
dose
merscov
neutrophil
number
prior
onset
signific
weight
loss
predict
diseas
sever
measur
weight
loss
per
mous
basi
therefor
neutrophil
peripher
blood
prior
onset
sever
clinic
diseas
may
serv
predict
biomark
sever
merscov
diseas
mice
elev
neutrophil
time
sarscov
patient
admiss
predict
advers
outcom
human
studi
describ
herein
highlight
predict
valu
clinic
translat
cbc
studi
emerg
viru
pathogenesi
techniqu
coupl
whole
bodi
plethysmographi
measur
pulmonari
function
bioplex
measur
cytokin
chemokin
level
lung
flow
cytometri
immunophenotyp
inflammatori
cell
lung
viral
load
histopatholog
yield
comprehens
view
emerg
viral
pathogenesi
increas
biolog
relev
mous
model
emerg
cov
diseas
therefor
inclus
cbc
elev
increas
biolog
relev
translat
futur
studi
emerg
viru
pathogenesi
well
preclin
evalu
therapeut
vaccin
